Koehler Pharmaceuticals (Beijing) Ltd. is a Joint Venture company of Dr. Franz Köhler Chemie GmbH with partners in China. The company will centrally manage and operate the business of CUSTODIOL (original Bretschneider HTK-solution) for cardiac and transplant surgery in the Chinese market as the exclusive distribution company. Furthermore, Koehler Pharmaceuticals (Beijing) Ltd. will conduct further research on myocardial protection and organ preservation together with clinical experts in China. In addition to pharmaceuticals for cardiac surgery and multi-organ transplantation, Koehler Pharmaceuticals (Beijing) Ltd. will introduce further products for intensive care medicine into the Chinese market.